Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

IMBRUVICA for Lymphoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 6 adverse event reports in the FDA FAERS database where IMBRUVICA was used for Lymphoma.

Most Reported Side Effects for IMBRUVICA

Side Effect Reports % Deaths Hosp.
Death 26 10.7% 26 2
Disease progression 25 10.3% 19 10
Diarrhoea 22 9.1% 4 14
Pneumonia 15 6.2% 8 12
Asthenia 14 5.8% 4 7
Atrial fibrillation 13 5.4% 2 4
Fatigue 13 5.4% 4 5
Dyspnoea 11 4.6% 2 5
Rash 10 4.1% 2 4
Anaemia 9 3.7% 4 8
Investigation 9 3.7% 0 9
Pyrexia 9 3.7% 3 9
Unevaluable event 9 3.7% 8 0
White blood cell count increased 9 3.7% 2 4
Back pain 8 3.3% 2 6

Other Indications for IMBRUVICA

Chronic lymphocytic leukaemia (111) Mantle cell lymphoma (50) Product used for unknown indication (36)

Other Drugs Used for Lymphoma

RITUXIMAB (3,142) CYCLOPHOSPHAMIDE (1,729) VINCRISTINE (1,452) LENALIDOMIDE (1,427) DOXORUBICIN (1,420) ETOPOSIDE (915) IBRUTINIB (896) PREDNISONE (672) METHOTREXATE (647) CYTARABINE (645)

Related Pages

IMBRUVICA Full Profile All Lymphoma Drugs IMBRUVICA Demographics IMBRUVICA Timeline